Metformin Reduces Risk of Long-COVID – Jun 23
Outpatient treatment with metformin reduced long COVID incidence by about 41%, with an absolute reduction of 4·1%, compared with placebo. Metformin has clinical benefits when used as outpatient treatment for COVID-19 and is globally available, low-cost, and safe. link to original paper The cumulative incidence of long COVID by day 300 was 6·3% (95% CI …